EdgarLookup

Gibson Christopher

Insider transactions at 2 companies

This page shows all SEC Form 4 filings attributed to Gibson Christopher. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.

IFF RXRX
Company Title Type Shares Price Value Date
RXRX Chief Executive Officer C 40,000 Dec 19, 2025
RXRX Chief Executive Officer Sale 40,000 $4.63 $185,200 Dec 4, 2025
RXRX Chief Executive Officer C 40,000 Nov 17, 2025
RXRX Chief Executive Officer Gift 20,000 Nov 4, 2025
RXRX Chief Executive Officer Sale 100,000 $5.70 $570,000 Oct 23, 2025
RXRX Chief Executive Officer Sale 100,000 $6.04 $604,000 Oct 10, 2025
RXRX Chief Executive Officer Sale 100,000 $4.76 $476,000 Sep 25, 2025
RXRX Chief Executive Officer Sale 100,000 $4.71 $471,000 Sep 10, 2025
RXRX Chief Executive Officer C 100,000 Aug 26, 2025
RXRX Chief Executive Officer Tax Withholding 40,390 $5.64 $227,800 Aug 15, 2025
RXRX Chief Executive Officer C 17,875 Aug 11, 2025
RXRX Chief Executive Officer Tax Withholding 36,197 $4.25 $153,837 May 15, 2025
RXRX Chief Executive Officer Sale 138,574 $6.04 $836,987 Mar 27, 2025
RXRX Chief Executive Officer Sale 20,000 $6.58 $131,600 Mar 6, 2025
RXRX Chief Executive Officer Tax Withholding 17,132 $10.64 $182,284 Feb 18, 2025
RXRX Chief Executive Officer Sale 20,000 $7.68 $153,600 Feb 5, 2025
RXRX Chief Executive Officer Award / Grant 16,809 Feb 3, 2025
RXRX Chief Executive Officer Sale 20,000 $7.31 $146,200 Jan 8, 2025
RXRX Chief Executive Officer Sale 20,000 $7.16 $143,200 Dec 4, 2024
RXRX Chief Executive Officer Tax Withholding 26,023 $6.18 $160,822 Nov 15, 2024
RXRX Chief Executive Officer Sale 20,000 $7.74 $154,800 Nov 14, 2024
RXRX Chief Executive Officer C 20,000 Oct 3, 2024
RXRX Chief Executive Officer Sale 20,000 $6.14 $122,800 Sep 5, 2024
RXRX Chief Executive Officer Option Exercise 5,000 $2.48 $12,400 Aug 30, 2024
RXRX Chief Executive Officer Option Exercise 5,000 $2.48 $12,400 Aug 29, 2024
RXRX Chief Executive Officer Option Exercise 5,000 $2.48 $12,400 Aug 28, 2024
RXRX Chief Executive Officer Option Exercise 5,000 $2.48 $12,400 Aug 27, 2024
RXRX Chief Executive Officer Option Exercise 5,000 $2.48 $12,400 Aug 26, 2024
RXRX Chief Executive Officer Option Exercise 5,000 $2.48 $12,400 Aug 23, 2024
RXRX Chief Executive Officer Tax Withholding 26,082 $6.69 $174,489 Aug 15, 2024
RXRX Chief Executive Officer Sale 30,000 $7.10 $213,000 Aug 7, 2024
RXRX Chief Executive Officer C 50,000 Jul 11, 2024
RXRX Chief Executive Officer Sale 50,000 $9.00 $450,000 Jun 5, 2024
RXRX Chief Executive Officer C 100,000 Jun 5, 2024
RXRX Chief Executive Officer Tax Withholding 26,082 $10.01 $261,081 May 15, 2024
RXRX Chief Executive Officer Sale 28,704 $8.47 $243,123 May 1, 2024
RXRX Chief Executive Officer Sale 25,000 $9.02 $225,500 Apr 3, 2024
RXRX Chief Executive Officer Sale 25,000 $10.10 $252,500 Mar 28, 2024
RXRX Chief Executive Officer C 10,000 Mar 6, 2024
RXRX Chief Executive Officer Tax Withholding 11,148 $12.43 $138,570 Feb 15, 2024
RXRX Chief Executive Officer Tax Withholding 3,233 $10.09 $32,621 Feb 9, 2024
RXRX Chief Executive Officer C 10,000 Feb 7, 2024
RXRX Chief Executive Officer Option Exercise 31,250 $2.48 $77,500 Jan 3, 2024
RXRX Chief Executive Officer C 10,000 Dec 6, 2023
RXRX Chief Executive Officer Tax Withholding 16,913 $7.18 $121,435 Nov 10, 2023
RXRX Chief Executive Officer Sale 4,000 $5.14 $20,560 Nov 1, 2023
RXRX Chief Executive Officer C 10,000 Oct 16, 2023
RXRX Chief Executive Officer Sale 59,794 $7.21 $431,115 Oct 4, 2023
RXRX Chief Executive Officer Gift 10,000 Sep 15, 2023
RXRX Chief Executive Officer Sale 33,765 $8.78 $296,457 Sep 6, 2023